The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background: Effective and sustainable implementation of physical activity (PA) in type 2 diabetes (T2D) health care has in general not been successful. Efficacious and contemporary approaches to support PA adherence and adoption are required. Objective: The primary objective of this study was to investigate the effectiveness of including an app-based (InterWalk) approach in municipality-based rehabilitation to increase moderate-and-vigorous PA (MVPA) across 52 weeks compared with standard care among individuals with T2D. Methods: The study was designed as a parallel-group, randomized trial with 52 weeks' intervention and subsequent follow-up for effectiveness (52 weeks from baseline). Participants were recruited between January 2015 and December 2016 and randomly allocated (2:1) into 12 weeks of (1) standard care + InterWalk app-based interval walking training (IWT; IWT group; n=140), or (2) standard care + the standard exercise program (StC group; n=74). Following 12 weeks, the IWT group was encouraged to maintain InterWalk app-based IWT (3 times per week for 30-60 minutes) and the StC group was encouraged to maintain exercise without structured support. Moreover, half of the IWT group (IWTsupport group, n=54) received additional motivational support following the 12-week program until 52-week follow-up. The primary outcome was change in objectively measured MVPA time (minutes/day) from baseline to 52-week follow-up. Key secondary outcomes included changes in self-rated physical and mental health-related quality of life (HRQoL), physical fitness, weight, and waist circumference. Results: Participants had a mean age of 59.6 (SD 10.6) years and 128/214 (59.8%) were men. No changes in MVPA time were observed from baseline to 52-week follow-up in the StC and IWT groups (least squares means [95% CI] 0.6 [-4.6 to 5.8] and -0.2 [-3.8 to 3.3], respectively) and no differences were observed between the groups (mean difference [95% CI] -0.8 [-8.1 to 6.4] minutes/day; P=.82). Physical HRQoL increased by a mean of 4.3 (95% CI 1.8 to 6.9) 12-item Short-Form Health Survey (SF-12) points more in the IWT group compared with the StC group (Benjamini-Hochberg adjusted P=.007) and waist circumference apparently decreased a mean of -2.3 (95% CI -4.1 to -0.4) cm more in the IWT group compared with the StC group but with a Benjamini-Hochberg adjusted P=.06. No between-group differences were observed among the remaining key secondary outcomes. Conclusions: Among individuals with T2D referred to municipality-based lifestyle programs, randomization to InterWalk app-based IWT did not increase objectively measured MVPA time over 52 weeks compared with standard health care, although apparent benefits were observed for physical HRQoL.

OriginalsprogEngelsk
Artikelnummere30602
TidsskriftJMIR mHealth and uHealth
Vol/bind10
Udgave nummer9
Antal sider18
ISSN2291-5222
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Participants and health professionals at the centers and hospital are acknowledged for their contribution to data collection and carrying through the interventions. Cecilie Fau Brinkløv and Malte Kongstad are acknowledged for their significant contributions to the study. The InterWalk app uses the REDCap facility at OPEN, Open Patient Data Explorative Network, Odense University Hospital, Region of Southern Denmark to collect data. The Centre for Physical Activity Research (CFAS) is supported by TrygFonden (grants IDs 101390, 20045, and 125132). During the study period, the Centre of Inflammation and Metabolism (CIM) was supported by a grant from the Danish National Research Foundation (DNRF55). CIM/CFAS is a member of DD2—the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant numbers 09-067009 and 09-075724). The study was further supported by TrygFonden, Augustinus Fonden, the Foundation for Prevention, and the Foundation for Intersectorial Research Projects. LSV was supported by a grant from the Municipality of Copenhagen, Denmark and The Danish Physiotherapist Foundation. MR-L was supported by a postdoctoral grant from the Danish Diabetes Academy supported by the Novo Nordisk Foundation and The Vissing Foundation. RC (the Parker Institute, Bispebjerg and Frederiksberg Hospital) is supported by a core grant from the Oak Foundation (OCAY-18-774-OFIL). HL was supported by a professor grant from the Municipality of Copenhagen, Denmark. The study funders were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and the decision to submit the paper for publication.

Publisher Copyright:
© 2022 JMIR Publications. All rights reserved.

Links

ID: 328232938